文献速递艾滋病与性传播感染

生殖支原体与盆腔炎性疾病关联的系统综述与Meta分析

Systematic Review and Meta-analysis of the Association Between Mycoplasma genitalium and Pelvic Inflammatory Disease (PID).
PubMed 文献 · Clin Infect Dis · 2026-01-01

该系统综述与Meta分析检索至2023年12月1日,纳入19项研究,评估生殖支原体与盆腔炎性疾病(PID)的关联及PID病例中生殖支原体检出率。生殖支原体感染与PID显著相关(合并OR=1.67,95%CI 1.24-2.24),PID中合并检出率为10.3%(95%CI 5.63-15.99)。作者认为这些数据支持在初次诊断PID时对女性进行生殖支原体检测。

要点

  • 生殖支原体感染与PID显著相关,合并OR=1.67(95%CI 1.24-2.24)。
  • PID病例中生殖支原体合并检出率为10.3%(95%CI 5.63-15.99)。
  • 作者认为数据支持在初次诊断PID时对女性检测生殖支原体。

核心结论

  • 生殖支原体与PID存在关联,合并OR=1.67(95%CI 1.24-2.24),即 odds 增加67%。
  • PID临床诊断中约1/10可检出生殖支原体,合并检出率10.3%(95%CI 5.63-15.99)。
  • 作者认为这些数据支持在初次诊断PID时对女性进行生殖支原体检测。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Medline和Web of Science至2023年12月1日。
  • 纳入采用既定临床标准评估女性PID并使用核酸扩增试验检测生殖支原体的研究。
  • 共纳入19项研究:10项估计生殖支原体与PID的关联,19项估计PID中生殖支原体检出率。
  • PROSPERO注册号CRD42022382156。

主要发现

  • 生殖支原体感染与PID显著相关,合并OR=1.67(95%CI 1.24-2.24)。
  • PID中生殖支原体合并检出率为10.3%(95%CI 5.63-15.99)。
  • 亚组和Meta回归分析显示,PID中生殖支原体检出率在美洲、住院和门诊两种场所开展的研究以及性传播感染高风险人群中最高。

临床怎么用

  • 作者认为这些数据支持在初次诊断PID时对女性进行生殖支原体检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differences in opinion concerning the contribution of Mycoplasma genitalium to pelvic inflammatory disease (PID) has resulted in inconsistencies across global testing and treatment guidelines. We conducted a systematic review and meta-analysis to determine the association between M. genitalium and PID and M. genitalium positivity within PID cases to provide a contemporary evidence base to inform clinical practice (PROSPERO registration: CRD42022382156). METHODS: PubMed, Embase, Medline, and Web of Science were searched to 1 December 2023 for studies that assessed women for PID using established clinical criteria and used nucleic acid amplification tests to detect M. genitalium. We calculated summary estimates of the (1) association of M. genitalium with PID (pooled odds ratio [OR]) and 2) proportion of PID cases with M. genitalium detected (pooled M. genitalium positivity in PID), using random-effects meta-analyses, with 95% confidence intervals (CI). RESULTS: Nineteen studies were included: 10 estimated M. genitalium association with PID, and 19 estimated M. genitalium positivity in PID. M. genitalium infection was significantly associated with PID (pooled OR = 1.67 [95% CI: 1.24-2.24]). The pooled positivity of M. genitalium in PID was 10.3% [95% CI: 5.63-15.99]. Subgroup and meta-regression analyses showed that M. genitalium positivity in PID was highest in the Americas, in studies conducted in both inpatient and outpatient clinic settings, and in populations at high risk of sexually transmitted infections. CONCLUSIONS: M. genitalium was associated with a 67% increase in odds of PID and was detected in about 1 of 10 clinical diagnoses of PID. These data support testing women for M. genitalium at initial PID diagnosis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Htaik K, Vodstrcil LA, Plummer EL, et al. Systematic Review and Meta-analysis of the Association Between Mycoplasma genitalium and Pelvic Inflammatory Disease (PID). Clin Infect Dis. 2026. PMID: 38845565. doi:10.1093/cid/ciae295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。